Speakers

Elsa Abranches holds a degree in Chemical Engineering and a Ph.D. in Stem Cell Biotechnology, from the Technical University of Lisbon, Portugal. Elsa has over 20 years of experience in stem cell biotechnology, standardization and Advanced Therapies regulation areas, ranging from applied research...

Michael Aigner is a biologist, who studied Biology at the University Regensburg, Bavaria, Germany and holds a PhD in medical Microbiology from the University Hospital Regensburg. In 2008, he moved to the University hospital in Erlangen, Germany and focused on adoptive T cell therapy. After first...

More than 30 years of experience in the pharma & biotech industries. Skilled senior executive with a broad range of experience leading global development, corporate strategy and a successful track record of innovation and development in the area of Orphan Drugs. Co-founder & CEO at Vivet...

Dr. Josephine Dietrich is a dedicated Staff Scientist at the Center for Regenerative Therapies Dresden (CRTD) in the group of Prof. Anke Fuchs, where she focuses on the development and translation of advanced cellular therapies from bench to bedside. With a strong background in cell and gene...

Dr James Duboff is a seasoned professional in the field of genomics and precision medicine, currently serving as the Strategic Partnerships Director at Genomics England. With a strong academic background in Biochemistry (MBiochem, University of Oxford) and Genetics (PhD, University of Cambridge)...

Mark Exley, Ph.D., is LIfT’s Chief Scientific Officer and Visiting Professor at Imperial College. He was Harvard Faculty for about 20 years and has over 40 years’ Immunology expertise, particularly Innate Immunology. He co-founded NKT Therapeutics and MiNK Therapeutics and is former CSO of...

Dr Katherine Forsey leads the Strategy To Accelerate Research (STAR) at the Charcot-Marie-Tooth Association (CMTA), driving a global, patient-focused agenda to develop treatments for CMT. She oversees a portfolio of more than 50 active research programmes, coordinates the CMTA-STAR Advisory...

Bobby is a world-renowned scientist and physician and accomplished strategic and organizational leader with more than 25 years of experience in medicine and biotechnology. He is co-founder and chief executive officer of Orchard Therapeutics, a global gene therapy leader recently acquired by Kyowa...

    Paul Gissen is a Clinical Professor of Paediatric Metabolic Medicine at the UCL Great Ormond Street Institute of Child Health, a position he has held since 2013, and an Honorary Consultant at Great Ormond Street Hospital for Children (GOSH). He obtained his medical degree with commendation...

Janet Glassford is an Expert Quality Assessor at the MHRA with a special interest in ATMPs. Her role includes the assessment of ATMP marketing authorisations, early access assessments, innovation licensing pathway applications and the provision of scientific advice. Since joining the Agency in...

George is a postdoctoral research fellow in the lab of Prof Sergi Castellano at the UCL Great Ormond Street Institute of Child Health. Following his PhD in Computer Science, he moved to biology to develop computational methods to address unmet needs in translational clinical research. His research...

Patrick Hopkinson is a Global Market Access/ HEOR expert with over 30 years experience. He is an independent consultant, founder and managing director of PHTA Consulting.  He is a senior leader in the life sciences industry with extensive expertise gained from working across multiple functions in...

Margareth Jorvid – MSc Pharm, MSc MTRA, MBA, FTOPRA Methra Uppsala AB CEO, Regulatory Affairs & Quality Assurance Margareth Jorvid has over 30 years of experience in Regulatory Affairs and has worked at the Swedish Medical Products Agency (MPA) as well as large and small pharmaceutical and...

Sophia N. Karagiannis is a distinguished Professor of Translational Cancer Immunology and Immunotherapy at King’s College London. She has a strong background in translational B‑cell and cancer immunology, with academic and biotechnology experience across the UK and USA. She leads a cancer antibody...

Rahul is a healthcare investor based in London, currently working as an Associate at UCB Ventures. He has a keen interest in partnering with innovative Digital health and Biotechnology startups and has supported UCB investments in ViaNautis Bio, Iris Medicine, Farnia Bio and Seamless...

Dr Gray Kueberuwa is Chief Executive Officer of ImmunoKey, a UK-based biotechnology company developing a modular CAR T-cell platform designed to address the key limitations of cell therapy in solid tumours. His work focuses on advancing next-generation, multi-targeted cell therapies toward clinical ...

Jon A Kyte has combined expertise as clinical oncologist and immunotherapy researcher and is Head of the Department for Clinical Cancer Research, Oslo University Hospital (OUS), and Professor at Faculty of Medicine University of Oslo (UiO). Kyte is also a Research Group Leader at Department Cancer...

  Biochemical engineer and regenerative medicine researcher pursuing an industrial PhD at UCL with Orchard Therapeutics, focused on non-viral ex vivo gene therapy process development for hematopoietic stem cells. Holds an MSc in Stem Cell and Gene Therapy Manufacturing and a BEng in Biochemical...

I am the CEO of Tetraneuron, a Spanish biotech company, advancing gene therapy solutions for Alzheimer’s disease and other neurodegenerative diseases. After several years supporting the company as an advisor and board member, I now lead its next phase of growth, as we prepare our lead candidate...

Dr John Maher is the scientific founder and chief scientific officer of Leucid Bio. He is also a clinical immunologist who leads the "CAR Mechanics" research group within King's College London. He played a key role in the early development of second generation (CD28) CAR technology...

Harris is Professor at King’s College London and founder of multiple successful spin-outs, he specializes in process engineering and works on integrating intelligent automation with engineering to accelerate the discovery and large-scale manufacture of genetic medicines. he is Expert in RNA...

Silvia Martin Lluesma is a pioneering leader in the field of advanced cell therapies, currently serving as the Co-director of the Advanced Cell Therapies Program at the Vall d'Hebron Institute of Oncology (VHIO), as Tenured Professor in Cell & Gene Therapy at Universidad CEU San Pablo...

Amphera B.V., a late clinical stage biotechnology company, develops MesoPher cell therapy for the treatment of cancer. Our lead indications are mesothelioma and pancreatic cancer. MesoPher is comprised of autologous dendritic cells loaded with our proprietary allogeneic tumour cell lysate...

Moin Saleem – Professor of Paediatric Renal Medicine, University of Bristol   Professor Saleem trained as an undergraduate at University College, London. Paediatric nephrology training at Great Ormond Street Hospital, London. He set up his independent laboratory programme in glomerular cell...

Dr. Lior Shaltiel is an awarded executive and scientist with a wealth of multidisciplinary international experience, specializing in innovative drug delivery systems. Since 2021, serving as the CEO and Director at NurExone Biologic Inc., an Canadian-Israeli biopharmaceutical company (TSXV:NRX)...

David Uguen serves as senior vice president and head of regulatory affairs of Orchard Therapeutics where he is responsible for steering the global regulatory strategy across all stages of the company’s pipeline of approved and investigational hematopoietic stem cell (HSC) gene therapies—spanning...

  Vincent van der Wel is the Director of Orfenix, which specialises in developing medicines that originate in academic research, ensuring they reach patients at an accessible price while maintaining sustainable returns for investors. By combining academic expertise with regulatory and clinical...

Darius Widera is Professor of Stem Cell Biology and Regenerative Medicine and Research Division Lead for Pharmaceutical and Chemical Sciences at the University of Reading. His lab is mainly interested in adult stem cells and their secretome, inflammatory signalling cascades in health and...